Clinical Trials in Austin

Showing 9581-9600 of 15,205 trials

Non-Significant Risk Study of Sebacia Microparticles in the Treatment of Facial Acne Vulgaris

NCT03303170

Prospective, randomized, controlled, parallel group clinical study with blinded assessment evaluating Sebacia Microparticles (SM) with Nd:Yag laser in facial inflammatory acne vulgaris

Acne Vulgaris

Sebacia, Inc.168 participantsStarted Sep 2017

Scottsdale, Arizona, United States • San Diego, California, United States • Miami, Florida, United States +8 more locations

COMPLETEDPhase 4< 1 mile

A Study of Crisaborole Ointment 2% in Children Aged 3-24 Months With Mild to Moderate Atopic Dermatitis

NCT03356977

This 4-week study will evaluate the safety, pharmacokinetics (PK), and efficacy of crisaborole ointment 2%, applied twice daily (BID) in subjects who are 3 months to less than 24 months of age with mild-to-moderate AD.

Atopic Dermatitis

Pfizer137 participantsStarted Jan 2018

Hot Springs, Arkansas, United States • San Diego, California, United States • San Diego, California, United States +29 more locations

Non-Significant Risk Study of Sebacia Microparticles in the Treatment of Facial Acne Vulgaris

A Study of Crisaborole Ointment 2% in Children Aged 3-24 Months With Mild to Moderate Atopic Dermatitis

Find Trials by Condition in Austin

Risk of Post-polypectomy Bleeding With Prophylactic Hemoclipping

Study to Evaluate the Safety and Efficacy of USL261 (Intranasal Midazolam) in Patients With Seizure Clusters

A Trial of IW-3718 for 8 Weeks in Patients With Symptomatic Gastroesophageal Reflux Disease (GERD)

Efficacy and Safety of Semaglutide Versus Dulaglutide as add-on to Metformin in Subjects With Type 2 Diabetes.

A Study of Solanezumab (LY2062430) in Participants With Prodromal Alzheimer's Disease

Abbott Laboratories Alinity s Blood Screening Assays - Clinical Evaluation Protocol

Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo

Validation of Lower Body Negative Pressure (LBNP) Model of Human Hemorrhage in Trauma Patients

A Study of Evacetrapib (LY2484595) in Participants With High Cholesterol

A Phase 2, 2-Stage, 2-Cohort Study of Talazoparib (BMN 673), in Locally Advanced and/or Metastatic Breast Cancer Patients With BRCA Mutation (ABRAZO Study)

Akt Inhibitor MK2206 or Everolimus in Treating Patients With Refractory Kidney Cancer

ABLATE Post Approval Study - Synergy Ablation Lesions for Non-Paroxysmal Atrial Fibrillation

Safety, Tolerability, and Efficacy Study of Idiopathic Pulmonary Fibrosis

Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease

Monoclonal Antibody Therapy and Combination Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma

A Study of Tabalumab (LY2127399) in Participants With Previously Treated Multiple Myeloma (MM)

e-NOBORI Observational Registry of Nobori DES

Trial of IMO-8400 in Adult Patients With Dermatomyositis